Skip to main content

. 2017 Jul 28;31(10):2278. doi: 10.1038/leu.2017.218

Erratum: A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

E J Cheadle, G Lipowska-Bhalla, S J Dovedi, E Fagnano, C Klein, J Honeychurch, T M Illidge

PMCID: PMC7609297 PMID: 28751765

Correction to: Leukemia (2017) 31, 1611–1621; doi:10.1038/leu.2016.352; published online 3 January 2017

Following the publication of this article, it was noted that the HTML version contained the wrong AAP date. The correct AAP date is 28 November 2016.

Footnotes

The online version of the original article can be found at 10.1038/leu.2016.352

ACTIONS

RESOURCES